₹226.87
▲ +2.56 +1.14%
17 Jul 2026
NSE Listed
Jagsonpal Pharmaceuticals (JAGSNPHARM)
Volume: 60,823Avg Vol 1W: 52,941.4Avg Vol 1M: 6,94,507.6552W Range:₹155₹301.65
Key Ratios
Checked 20h agoMarket Cap₹1,515 Cr
Current Price₹226.87
Previous Close₹224.31
High / Low (52w)₹301.65 / ₹155
Volume60,823
Avg Vol (1W)52,941.4
Avg Vol (1M)6,94,507.65
Stock P/E179.45
Book Value₹41.25
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹277 Cr
Revenue Growth—
Profit Margin—
Total Debt₹8 Cr
Shares Outstanding—
Face Value₹2
EPS (TTM)₹1.25
P/B5.44
Debt / Equity—
50 DMA₹217.5
200 DMA₹200.46
Day change+1.14%
Price Chart
₹226.87▼ 7.89% · 1Y
2025-07-162026-07-15
20-day avg volume: 6.9L shares
Cons
- Revenue fell 25% YoY.
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 179.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹61 Cr | ₹75 Cr | ₹74 Cr | ₹59 Cr | ₹76 Cr | ₹74 Cr | ₹73 Cr | ₹64 Cr |
| EBITDA | ₹11 Cr | ₹16 Cr | ₹16 Cr | ₹9 Cr | ₹15 Cr | ₹17 Cr | ₹17 Cr | ₹12 Cr |
| Net Profit | ₹5 Cr | ₹11 Cr | ₹32 Cr | ₹7 Cr | ₹11 Cr | ₹13 Cr | ₹11 Cr | ₹9 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹127 Cr | ₹168 Cr | ₹161 Cr | ₹192 Cr | ₹221 Cr | ₹242 Cr | ₹218 Cr | ₹277 Cr |
| EBITDA | ₹-11 Cr | ₹10 Cr | ₹10 Cr | ₹22 Cr | ₹27 Cr | ₹39 Cr | ₹31 Cr | ₹51 Cr |
| Net Profit | ₹-12 Cr | ₹7 Cr | ₹8 Cr | ₹17 Cr | ₹19 Cr | ₹27 Cr | ₹22 Cr | ₹55 Cr |
| EPS | -4.41 | 2.75 | 3 | 6.51 | 7.2 | 10.2 | 3.39 | 8.22 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹136 Cr | ₹147 Cr | ₹164 Cr | ₹164 Cr | ₹195 Cr | ₹217 Cr | ₹278 Cr | ₹317 Cr |
| Total Liabilities | ₹31 Cr | ₹36 Cr | ₹42 Cr | ₹31 Cr | ₹36 Cr | ₹30 Cr | ₹38 Cr | ₹41 Cr |
| Equity | ₹104 Cr | ₹111 Cr | ₹122 Cr | ₹133 Cr | ₹159 Cr | ₹187 Cr | ₹240 Cr | ₹276 Cr |
| Total Debt | — | — | — | — | — | — | — | ₹8 Cr |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹31 Cr | ₹14 Cr | ₹54 Cr | ₹44 Cr | ₹63 Cr | ₹47 Cr |
| Investing | ₹-2 Cr | ₹-26 Cr | ₹-58 Cr | ₹-25 Cr | ₹-45 Cr | ₹-36 Cr |
| Financing | ₹-7 Cr | ₹-18 Cr | ₹0 Cr | ₹-9 Cr | ₹-12 Cr | ₹-12 Cr |
| Free Cash Flow | ₹31 Cr | ₹14 Cr | ₹54 Cr | ₹44 Cr | ₹63 Cr | ₹47 Cr |
Shareholding
Promoter 69.36% Institutions 2.77% Public 27.87%
About Jagsonpal Pharmaceuticals
Healthcare · Drug Manufacturers - Specialty & Generic
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
www.jagsonpal.com ↗Efficiency & Working Capital
ROCE20.6%
Interest Coverage53.3
Dividend Payout—
Debtor Days18 d
Inventory Days21 d
Payable Days13 d
Cash Conversion Cycle25 d
Working Capital Days39 d
Shareholding Details
As of 2026-06-30
Promoter69%
FII2.3%
DII0.6%
Institutions2.9%
Public28%
Promoter Pledge0%
No. of Shareholders24,181
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68.7% | 68.5% | 68.1% | 68% | 68% | 67.8% | 67.8% | 67.6% | 67.5% | 67.4% | 67.9% | 69% |
| FIIs | 0.4% | 0.5% | 0.7% | 1.1% | 2.3% | 2.1% | 2.1% | 2.2% | 2.1% | 2.1% | 2.4% | 2.3% |
| DIIs | 0.8% | 0% | 0.8% | 0.8% | 0.1% | 0% | 0% | 0.1% | 0.1% | 0.1% | 0.2% | 0.6% |
| Public | 30.1% | 31% | 30.3% | 30% | 29.6% | 30.1% | 30.1% | 30.1% | 30.2% | 30.3% | 29.4% | 28% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 16,041 | 15,785 | 16,282 | 15,748 | 15,633 | 18,471 | 21,085 | 22,899 | 24,653 | 24,895 | 26,264 | 24,181 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Aresko Progressive Private Limited (trustee Of Aresko Progressive Trust, A In The Capacity Of Repres | Shareholding of Promoter and Promoter Group | 20.3% | 1.33 Cr |
| Infinity Capital (formerly Infinity Holdings Sidecar1) | Shareholding of Promoter and Promoter Group | 18.1% | 1.19 Cr |
| Infinity Holdings | Shareholding of Promoter and Promoter Group | 16.8% | 1.10 Cr |
| Infinity Portfolio Holdings | Shareholding of Promoter and Promoter Group | 8.7% | 57,17,950 |
| Rajpal Singh Kochhar | Shareholding of Promoter and Promoter Group | 4.6% | 30,30,400 |
| Manish Gupta | Public Shareholding | 3.1% | 20,26,020 |
| Authum Investment And Infrastructure Limited | Public Shareholding | 1.5% | 9,67,965 |
| Sanjiv Kumar Dudeja | Public Shareholding | 1.4% | 9,26,360 |
| Lincoln P Coelho | Public Shareholding | 1.2% | 7,75,500 |
| Prithipal Singh Kochhar | Shareholding of Promoter and Promoter Group | 0.4% | 2,69,675 |
| Inderpal Singh Kochhar | Shareholding of Promoter and Promoter Group | 0.3% | 1,83,750 |
| Ishpinder Kaur Kochhar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Infinity Consumer Holdings | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rakshit Organisational Operations And Transformations Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aresko Life Sciences Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aresko Restaurants Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aresko Services Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aresko Family Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aresko Realtors Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sewara Buildtech Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Naari Pharma Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| I. K. Enterprises Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Alga Hospitality Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aresko Estates Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bagri Fort Resorts Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Rajpal Singh Kochhar | 0 | 0% | 2026-06-30 |
| Prithipal Singh Kochhar | 0 | 0% | 2026-06-30 |
| Inderpal Singh Kochhar | 0 | 0% | 2026-06-30 |
| Ishpinder Kaur Kochhar | 0 | 0% | 2026-06-30 |
| Aresko Progressive Private Limited (trustee Of Aresko Progressive Trust, A In The Capacity Of Repres | 0 | 0% | 2026-06-30 |
| Rakshit Organisational Operations And Transformations Pvt. Ltd. | 0 | 0% | 2026-06-30 |
| Aresko Life Sciences Private Limited | 0 | 0% | 2026-06-30 |
| Aresko Restaurants Private Limited | 0 | 0% | 2026-06-30 |
| Aresko Services Limited | 0 | 0% | 2026-06-30 |
| Aresko Family Private Limited | 0 | 0% | 2026-06-30 |
| Aresko Realtors Private Limited | 0 | 0% | 2026-06-30 |
| Sewara Buildtech Private Limited | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Manish Gupta | Executive Director & MD | 2025 |
| Harsha Raghavan | Chairperson | 2025 |
| Pallavi Dinodia | Independent Non Exe. Director | 2025 |
| Debasis Bikash Nandy | Independent Non Exe. Director | 2025 |
| Prithipal Singh Kochhar | Non Executive Director | 2025 |
| Pratham Rawal | Company Sec. & Compli. Officer | 2025 |
| Radhika Dudhat | Independent Non Exe. Director | 2025 |
| Rajpal Singh Kochhar | Chairman Emeritus | 2025 |
| Anil Matai | Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals business | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 15 | 13 | 13 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| buyback | 2026-05-14 | ₹250 max | — |
| dividend | 2025-09-12 | ₹2.5 (125%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 8 | 4 | 12 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 4 | 3 | 7 |
Insider / Designated-Person Trades
3 recent disclosure(s)
Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments PartnershipDisposal · 1,14,55,500
Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments PartnershipDisposal · 2,25,737
Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments PartnershipDisposal · 1,99,763
Substantial Acquisitions (SAST)
3 disclosure(s)
Market13/09/2024 · 22,87,180
-13/09/2024 · 22,87,180
Market13/09/2024 · 22,87,180
Company Information
Incorporated1978
ChairmanHarsha Raghavan
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]; [email protected]
📍 T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Iware Supplychain Ser Ltd.Indian Wood Products Co LimitedLe Travenues Technology LimitedIykot Hitech Toolroom Ltd.IZMO LimitedJagran Prakashan LimitedJai Balaji Industries Ltd.Jai Corp LimitedJainam Fer Alloys (I) Ltd.Jainik Power Cables Ltd.Jain Resource Recycling LimitedNandani Creation LimitedAll “J” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search